CONMED CNMD officer reports RSU vesting and tax share sale

Q: How many CONMED (CNMD) shares were sold or withheld for taxes?

A total of 118 shares of CONMED common stock were disposed of at $40.63 per share to satisfy tax withholding related to the RSU settlement.

Q: How many CONMED (CNMD) shares does the officer hold after this transaction?

After the reported transactions, the officer directly owns 257 shares of CONMED common stock.

Q: How many RSUs remain outstanding for the CONMED (CNMD) officer after the Form 4 event?

Following the settlement, the officer holds 750 RSUs , each representing a contingent right to receive one share of CONMED common stock.

Q: What role does the reporting person hold at CONMED (CNMD)?

The reporting person, Richard Glaze, serves as CONMED’s Chief Information Officer .

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

CONMED Corporation’s Chief Information Officer, Richard Glaze, reported the settlement of restricted stock units in a Form 4 filing. On 11/20/2025, 375 RSUs were converted into shares of common stock at an exercise price of $0 per share, increasing his directly held common stock to 375 shares.

To cover taxes due on this vesting, 118 shares of common stock were disposed of at $40.63 per share, leaving 257 shares of common stock held directly after the withholding. Following the transaction, 750 RSUs remain outstanding, each representing a contingent right to receive one share of CONMED common stock.

Insider Trade Summary

375 shares exercised/converted

Mixed 3 txns

Insider Glaze Richard

Role Chief Information Officer

Type	Security	Shares	Price	Value
Exercise	RSUs (Restricted Stock Units)	375	$0.00	--
Exercise	Common Stock	375	$0.00	--
Tax Withholding	Common Stock	118	$40.63	$5K

Holdings After Transaction: RSUs (Restricted Stock Units) — 750 shares (Direct); Common Stock — 375 shares (Direct)

Footnotes (1)

[object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/21/2025 - 03:39 PM

FAQ

What insider transaction did CONMED (CNMD) report in this Form 4?

CONMED (CNMD) reported that its Chief Information Officer, Richard Glaze, settled 375 restricted stock units (RSUs), which were converted into shares of common stock.

How many CONMED (CNMD) shares did the officer acquire and at what price?

The officer acquired 375 shares of CONMED common stock upon RSU vesting at an exercise price of $0 per share.

How many CONMED (CNMD) shares were sold or withheld for taxes?

A total of 118 shares of CONMED common stock were disposed of at $40.63 per share to satisfy tax withholding related to the RSU settlement.

How many CONMED (CNMD) shares does the officer hold after this transaction?

After the reported transactions, the officer directly owns 257 shares of CONMED common stock.

How many RSUs remain outstanding for the CONMED (CNMD) officer after the Form 4 event?

Following the settlement, the officer holds 750 RSUs, each representing a contingent right to receive one share of CONMED common stock.

What role does the reporting person hold at CONMED (CNMD)?

The reporting person, Richard Glaze, serves as CONMED’s Chief Information Officer.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glaze Richard

(Last)

(First)

(Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO

33773

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Information Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/20/2025		M		375	A	$0	375	D
Common Stock	11/20/2025		F		118	D	$40.63	257	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
RSUs (Restricted Stock Units)	$0	11/20/2025		M			375	⁽¹⁾	11/20/2033	Common Stock	375	$0	750	D

Explanation of Responses:

1. Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each RSU represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation.

	/s/ Thomas Fistek for Richard Glaze by Power of Attorney	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR